Granulocytic and monocytic lineage abnormalities detected by flow cytometry
| . | MDS patients (%) . |
|---|---|
| Hypogranulation of neutrophils by orthogonal light scatter | 38/45 (84) |
| CD64−granulocytes | 27/41 (66) |
| Discrete blasts by CD45 vs orthogonal light scatter | 24/42 (53) |
| CD56+granulocytes | 97/33 (21) |
| CD56+ monocytes | 11/33 (33) |
| CD11b/CD16 pattern abnormal | 19/27 (70) |
| CD13/CD16 pattern abnormal | 21/27 (78) |
| CD10−granulocytes | 5/45 (11) |
| Bright CD2+ myeloid blasts | 12/45 (27) |
| Myeloid lineage expressing nonmyeloid antigens (eg, B-cell antigen CD22 or T-cell antigen CD7) | 17/45 (38) |
| . | MDS patients (%) . |
|---|---|
| Hypogranulation of neutrophils by orthogonal light scatter | 38/45 (84) |
| CD64−granulocytes | 27/41 (66) |
| Discrete blasts by CD45 vs orthogonal light scatter | 24/42 (53) |
| CD56+granulocytes | 97/33 (21) |
| CD56+ monocytes | 11/33 (33) |
| CD11b/CD16 pattern abnormal | 19/27 (70) |
| CD13/CD16 pattern abnormal | 21/27 (78) |
| CD10−granulocytes | 5/45 (11) |
| Bright CD2+ myeloid blasts | 12/45 (27) |
| Myeloid lineage expressing nonmyeloid antigens (eg, B-cell antigen CD22 or T-cell antigen CD7) | 17/45 (38) |
MDS indicates myelodysplatic syndrome.